| Source Date | Board Meeting Date | Details |
| 31 Dec 2025 | 15 Jan 2026 | Quarterly Results |
| 30 Sep 2025 | 15 Oct 2025 | Quarterly Results |
| 30 Jun 2025 | 15 Jul 2025 | Quarterly Results |
| 01 Apr 2025 | 17 Apr 2025 | Final Dividend & Audited Results & Employees Stock Option Plan |
| 31 Dec 2024 | 15 Jan 2025 | Quarterly Results |
| 01 Oct 2024 | 15 Oct 2024 | Quarterly Results |
| 01 Jul 2024 | 15 Jul 2024 | Quarterly Results |
| 15 Apr 2024 | 18 Apr 2024 | Final Dividend & Audited Results |
| 01 Apr 2024 | 18 Apr 2024 | Audited Results |
| 29 Dec 2023 | 12 Jan 2024 | Quarterly Results |
| 29 Sep 2023 | 13 Oct 2023 | Quarterly Results |
| 30 Jun 2023 | 21 Jul 2023 | Quarterly Results |
| 31 Mar 2023 | 26 Apr 2023 | Audited Results & Final Dividend |
| 30 Dec 2022 | 20 Jan 2023 | Quarterly Results |
| 30 Sep 2022 | 21 Oct 2022 | Quarterly Results |
| 26 Jul 2022 | 29 Jul 2022 | Preferential Issue of shares & Employees Stock Option Plan inter-alia to consider: i) the matter pertaining to raising of funds by way of issue of equity shares and / or other securities of the Company by way of preferential issue, subject to approvals of shareholders through postal ballot process and regulatory approvals, as may be applicable; and ii) formulation of Employee Stock Option Scheme in terms of SEBI (Share Based Employee Benefits and Sweat Equity) regulations, 2021, subject to approval of shareholders through postal ballot |
| 30 Jun 2022 | 19 Jul 2022 | Quarterly Results |
| 31 Mar 2022 | 26 Apr 2022 | Final Dividend & Audited Results & Inter alia, To consider raising of funds by way of issuance of Non-Convertible debentures in the nature of subordinated debt as per IRDAI (Other Forms of Capital) Regulations, 2015. These funds are proposed to be raised to further strengthen the cash reserves of the Company post cash payout as part-consideration for acquisition of Exide Life Insurance Company Limited |
| 31 Dec 2021 | 21 Jan 2022 | Quarterly Results |
| 30 Sep 2021 | 22 Oct 2021 | Quarterly Results |
